S. Vincent Rajkumar

1994–2025 年に発表

477
論文数
114,462
被引用数
163
h 指数
463
i10 指数

被引用数

S. Vincent Rajkumar の年別被引用数1974 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 4 件1998 年: 被引用 2 件1999 年: 被引用 9 件2000 年: 被引用 15 件2001 年: 被引用 55 件2002 年: 被引用 90 件2003 年: 被引用 185 件2004 年: 被引用 286 件2005 年: 被引用 311 件2006 年: 被引用 391 件2007 年: 被引用 553 件2008 年: 被引用 528 件2009 年: 被引用 688 件2010 年: 被引用 709 件2011 年: 被引用 857 件2012 年: 被引用 768 件2013 年: 被引用 909 件2014 年: 被引用 873 件2015 年: 被引用 753 件2016 年: 被引用 958 件2017 年: 被引用 803 件2018 年: 被引用 755 件2019 年: 被引用 2,830 件2020 年: 被引用 3,389 件2021 年: 被引用 3,180 件2022 年: 被引用 2,500 件2023 年: 被引用 1,764 件2024 年: 被引用 3,364 件2025 年: 被引用 1,416 件2026 年: 被引用 38 件1975〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,730 件、この内訳の 27.5%イタリア: 引用元論文 1,446 件、この内訳の 6.9%イギリス: 引用元論文 1,286 件、この内訳の 6.2%中国: 引用元論文 1,263 件、この内訳の 6.1%ドイツ: 引用元論文 1,243 件、この内訳の 6%フランス: 引用元論文 1,074 件、この内訳の 5.1%スペイン: 引用元論文 932 件、この内訳の 4.5%カナダ: 引用元論文 662 件、この内訳の 3.2%オランダ: 引用元論文 639 件、この内訳の 3.1%オーストラリア: 引用元論文 517 件、この内訳の 2.5%ギリシャ: 引用元論文 502 件、この内訳の 2.4%日本: 引用元論文 439 件、この内訳の 2.1%
0%27.5%その他 24.4%

分野

  • Medicine68.2%
  • Biochemistry, Genetics and Molecular Biology24%
  • Immunology and Microbiology3.2%
  • Computer Science1%
  • Psychology0.7%
  • Engineering0.4%
  • その他2.5%

トピック

  • Multiple Myeloma Research and Treatments16.3%
  • Protein Degradation and Inhibitors6.1%
  • Amyloidosis: Diagnosis, Treatment, Outcomes3.8%
  • Peptidase Inhibition and Analysis3.6%
  • Lymphoma Diagnosis and Treatment2.8%
  • Ubiquitin and proteasome pathways2.7%
  • その他64.7%

共著者

全論文

検索で開く
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Hochhaus, Patty M. Jansen, Kennosuke Karube, Werner Kempf, Joseph D. Khoury, Hiroshi Kimura, Wolfgang Hiddemann, Alexandra E. Kovach, Shaji Kumar, Alexander J. Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao‐Qiu Li, Megan S. Lim, Weiping Liu, Abner Louissaint, Andrea N. Marcogliese, L. Jeffrey Medeiros, Michael Michal, Roberto N. Miranda, Christina Mitteldorf, Santiago Montes‐Moreno, William G. Morice, Valentina Nardi, Kikkeri N. Naresh, Yasodha Natkunam, Siok‐Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa Pulitzer, S. Vincent Rajkumar, Andy C. Rawstron, Karen L. Rech, Andreas Rosenwald, Jonathan Said, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William A. Sewell, Reiner Siebert, Aliyah R. Sohani, Reuben Tooze, Alexandra Traverse‐Glehen, Francisco Vega, B. Vergier, Ashutosh Wechalekar, Brent L. Wood, Luc Xerri, Wenbin Xiao - Leukemia 2022 被引用: 3,736

  2. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau - The Lancet Oncology 2016 被引用: 2,995

  3. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 被引用: 4,869

  4. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 被引用: 1,506

  5. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management

    著者: - American Journal of Hematology 2022 被引用: 845

  6. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Moreau - Journal of Clinical Oncology 2015 被引用: 2,178

  7. Multiple myeloma

    著者: , , , , , , , - Nature Reviews Disease Primers 2017 被引用: 1,166

  8. Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 1,124

  9. Prevalence of Monoclonal Gammopathy of Undetermined Significance

    著者: , , , , , , , , - New England Journal of Medicine 2006 被引用: 1,409

  10. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

    著者: , , , , , , - New England Journal of Medicine 2018 被引用: 635

  11. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2011 被引用: 1,034

  12. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn ほか 30 名 - The Lancet 2019 被引用: 636

  13. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , - The Lancet 2016 被引用: 888

  14. International uniform response criteria for multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on behalf of the International Myeloma Working Group - Leukemia 2006 被引用: 2,639

  15. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

    著者: , , , , , , , , , , , - Blood 2009 被引用: 1,121

  16. Multiple myeloma current treatment algorithms

    著者: , - Blood Cancer Journal 2020 被引用: 359

  17. Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

    著者: , , , , , , , , , , , - New England Journal of Medicine 2007 被引用: 919

  18. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

    著者: , , , , , , , , , , , , - Mayo Clinic Proceedings 2003 被引用: 2,431

  19. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baldeep Wirk, Matthew T. Drake, Michèle Cavo, Juan José Lahuerta, Suzanne Lentzsch - The Lancet Oncology 2019 被引用: 496

  20. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    著者: , , , , , , , , , , , , , , , - Leukemia 2013 被引用: 1,396

  21. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Cancer Journal 2020 被引用: 275

  22. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús F. San Miguel, Kenneth C. Anderson, Edward A. Stadtmauer, Rao Prabhala, Phillip McCarthy, Nikhil C. Munshi - The Lancet Haematology 2022 被引用: 191

  23. Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management

    著者: - American Journal of Hematology 2024 被引用: 405

  24. Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 311